stockrowMaravai LifeSciences Holdings, Inc. (MRVI) vs Vir Biotechnology, Inc. (VIR)
- Maravai LifeSciences Holdings, Inc. MRVI 7.52 +7.74%
- Vir Biotechnology, Inc. VIR 12.19 +10.62%
Maravai LifeSciences Holdings, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Vir Biotechnology, Inc. are of similar size ($1.9B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,696.0% against 10.7%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−30.8% vs −61.0%) and the higher return on invested capital (−13.6% vs −30.3%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 10 and Vir Biotechnology, Inc. on 8.
Valuation
Profitability
| Metric | MRVI | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 39.15% | 99.99% | 68.51% |
| Operating margin | (45.38%) | (69.82%) | 0.00% |
| Net margin | (30.83%) | (61.03%) | 0.00% |
| Free cash flow margin | (5.89%) | (46.87%) | 0.00% |
| Return on equity | (17.01%) | (21.84%) | (51.96%) |
| Return on assets | (9.06%) | (17.34%) | (46.06%) |
| Return on invested capital | (13.62%) | (30.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack